Drug
Ortho Cyclen
Ortho Cyclen is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_1
3
60%
Ph phase_4
1
20%
Ph phase_2
1
20%
Phase Distribution
3
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 13 (60.0%)
Phase 21 (20.0%)
Phase 41 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Elagolix for Fertility Enhancement Clinical Trial
NCT04039204
completedphase_1
A Study of LY2216684 in Healthy Females
NCT01373931
completedphase_4
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
NCT01475513
completedphase_1
Study of Combined Oral Contraceptive Effects in Female Subjects
NCT02157467
completedphase_1
Drug Interaction - Oral Contraceptive
NCT00399685
Clinical Trials (5)
Showing 5 of 5 trials
NCT04039204Phase 2
Elagolix for Fertility Enhancement Clinical Trial
NCT01373931Phase 1
A Study of LY2216684 in Healthy Females
NCT01475513Phase 4
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
NCT02157467Phase 1
Study of Combined Oral Contraceptive Effects in Female Subjects
NCT00399685Phase 1
Drug Interaction - Oral Contraceptive
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5